Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

PureTech Health’s Founded Entity Akili announces positive data from adult ADHD trial

May 4, 2023 Medical Communications ADHD, Akili, Neurology, PureTech Health, clinical trials

Clinical-stage biotherapeutics company PureTech Health has reported that its Founded Entity Akili, a digital medicine company, has announced positive topline …
News

FDA approves world’s first RSV vaccine

May 4, 2023 Medical Communications FDA, RSV, Vaccine, Virology

The US Food and Drug Administration (FDA) has announced that it has approved the world’s first respiratory syncytial virus (RSV) …
News

NICE recommends Otsuka’s Lupkynis (voclosporin) in combination treatment for active lupus nephritis

May 4, 2023 Medical Communications MHRA, NICE, Nephrology, Otsuka Pharmaceuticals, lupus nephritis

Otsuka Pharmaceuticals has announced that the National Institutes for Health and Care Excellence (NICE) has recommended Lupkynis (voclosporin) in combination …
News

Avadel Pharmaceuticals granted FDA final approval for narcolepsy drug

May 3, 2023 Medical Communications FDA, FDA Approval, Neurology, avadel pharmaceuticals, narcolepsy, new drug approvals

Irish biopharmaceutical company Avadel Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted final approval and …
News

Tempus receives FDA Premarket Approval for in vitro diagnostic scan

May 3, 2023 Medical Communications Diagnostics, FDA, Oncology, Tempus, in vitro

US-based artificial intelligence (AI) and precision medicine company Tempus has announced that the US Food and Drug Administration (FDA) has …
News
markus-spiske-dnbtfbnqlrc-unsplash_1

GSK’s RSV vaccine candidate gains positive EMA CHMP opinion

April 27, 2023 Medical Communications

GSK has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has shared a …
News

FDA approves first orally-administered faecal microbiota product for preventing serious gut infection

April 27, 2023 Medical Communications

The US Food and Drug Administration (FDA) has announced that it has approved the first orally-ingested faecal microbiota product for …
News
anirudh-djo3injpaoe-unsplash_3

NICE recommends two CAR T treatments for blood cancers to the Cancer Drugs Fund

April 27, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has announced that it is recommending two personalised immunotherapy treatments to …
News

FDA shares safety warning on amniotic fluid eyedrops

April 26, 2023 Medical Communications

The US Food and Drug Administration (FDA) has released a Public Safety Notification on eyedrops containing amniotic fluid currently being …
News
max-bender-w5bn80xghre-unsplash_1

FDA grants accelerated approval for QALSODY (tofersen) as ALS treatment

April 26, 2023 Medical Communications

Biogen has announced that the US Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100mg/15ml injection for the treatment …
News
national-cancer-institute-l8twzt4ccvq-unsplash_1

UCB and Huma Therapeutics collaborate on digital health solution to improve rare disease management

April 26, 2023 Medical Communications

Digital health company Huma Therapeutics and biopharmaceutical company UCB are partnering to offer a digital technology solution to aid patients …
News
jair-lazaro-0lrjo37r6nk-unsplash

Abbott announces two FDA clearances for life support system

April 26, 2023 Medical Communications

US-based medical devices and healthcare company Abbott has announced two new clearances from the US Food and Drug Administration (FDA) …
News
national-cancer-institute-kmvohcb-w5g-unsplash_1

EMA validates marketing authorisation application for Jemperli with chemotherapy

April 25, 2023 Medical Communications

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication …
News
hal-gatewood-_jbclosdsd4-unsplash

NICE publishes Final Appraisal Document for multiple myeloma drug

April 25, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has submitted a Final Appraisal Document (FAD) for the use of …
News
robina-weermeijer-so1l3jsdd3y-unsplash_2

AstraZeneca and Ionis share positive results from phase 3 trial for eplontersen

April 25, 2023 Medical Communications

AstraZeneca and Ionis have announced positive results from their phase 3 NEURO-TTRansform trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026